Extended Buprenorphine-Naloxone Treatment for Opioid-Addicted Adolescents: A Qualified Success
Fewer adolescents who received treatment for 12 weeks than for 14 days had opioid-positive urine tests at 4 and 8 weeks, but not at 12 weeks or 1 year.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)